Stay updated on Pembrolizumab in HER2+ Gastric Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in HER2+ Gastric Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-25T22:08:25.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page has been updated to include new drug identifiers and a revision number, while significant details about the study's design and treatment protocols have been removed.
    Difference
    15%
    Check dated 2025-04-18T16:25:35.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The date has been updated from March 25, 2025, to March 17, 2025.
    Difference
    0.1%
    Check dated 2025-04-11T11:47:56.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-03T22:09:52.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new revision version (v2.14.3) and a new date for the results first posted, changing from March 17, 2025, to March 25, 2025.
    Difference
    0.1%
    Check dated 2025-03-27T14:58:23.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect new results and criteria for a clinical study involving pembrolizumab and trastuzumab for HER2 positive gastric cancer, with specific details on treatment protocols and efficacy measures. The results reporting dates have also been updated.
    Difference
    14%
    Check dated 2025-03-20T10:43:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in HER2+ Gastric Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.